🇺🇸 FDA

Company profile · Sponsor

Shire

E37FFB3 · NMPA pharma CN
Pipeline
9
Drugs
0
Patents
0

Quick answer

Shire (E37FFB3) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E37FFB3
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (9)

Search pipeline →

  1. Maribavir

    Shire

    Cytomegalovirus (CMV)

    phase 3 small molecule completed

    2 trials

  2. Ontamalimab

    Shire

    Crohn's Disease

    phase 3 small molecule terminated

    1 trial

  3. SHP615

    Shire

    Nervous System Diseases

    phase 3 small molecule completed

    1 trial

  4. velaglucerase alfa

    Shire

    Gaucher Disease

    phase 3 mab completed

    1 trial

  5. Recombinant human arylsulfatase A

    Shire

    Metachromatic Leukodystrophy (MLD)

    phase 2 mab completed

    1 trial

  6. SHP611

    Shire

    Metachromatic Leukodystrophy (MLD)

    phase 2 small molecule active

    1 trial

  7. rhASA

    Shire

    Late Metachromatic Leukodystrophy (MLD)

    phase 2 small molecule active

    1 trial

  8. rhASA

    Shire

    Late Metachromatic Leukodystrophy (MLD)

    phase 2 small molecule active

    1 trial

  9. Elaprase for intravenous (IV) infusion

    Shire

    Hunter Syndrome

    approved small molecule completed

    1 trial

Frequently asked questions

What is Shire?

Shire (E37FFB3) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Shire sponsor?

We track 9 ClinicalTrials.gov-linked programs for Shire, including Maribavir and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Shire company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.